GASTROClear for Patients
Accurate, Actionable, and Affordable
The world’s first approved* microRNA blood test for early detection of gastric cancer.
MiRXES GASTROClear is a qPCR-based diagnostic test kit that measures 12 microRNA biomarkers linked to gastric cancer and calculates a cancer risk score for each patient using a proprietary algorithm that has been clinically validated.
The test was developed by MiRXES in collaboration with the Singapore Gastric Cancer Consortium (SGCC), the Diagnostic Development (DxD) Hub of Singapore’s Agency for Science, Technology and Research (A*STAR), National University Hospital (NUH), and Tan Tock Seng Hospital (TTSH).
* CE IVD marked and approved for IVD use by Singapore’s Health Sciences Authority
1 , et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
GASTROClear microRNA test
GASTROClear test can be ordered by healthcare providers through MiRXES partner diagnostic labs
Tan Tock Seng Hospital (TTSH)
Molecular Diagnostic Lab (MDL)
National University Hospital (NUH)
Molecular Diagnosis Centre (MDC)
The science and story of GASTROClear
Interview with Prof. Yeoh Khay Guan, Lead Principal Investigator of the Singapore Gastric Cancer Consortium (SGCC), and Prof. Too Heng-Phon, Co-founder of MiRXES.